AHA 2023 Insights

 

 
 

 

AHA 2023 Insights: Target-HTN: Trial on the Safety and Efficacy of Lorundrostat (MLS-101) in Patients with Uncontrolled Hypertension

353 views
November 20, 2023
Comments 1
Login to view comments. Click here to Login